OPKO Health
OPK
#5857
Rank
NZ$1.84 B
Marketcap
NZ$2.32
Share price
-0.74%
Change (1 day)
-13.10%
Change (1 year)

OPKO Health (OPK) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.68 Billion

According to OPKO Health 's latest financial reports the company's total debt is NZ$0.68 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

OPKO Health - Total debt on balance sheet (from 1997 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.89 B73.21%
2023-12-31NZ$0.51 B7.3%
2022-12-31NZ$0.48 B29.03%
2021-12-31NZ$0.37 B-8.64%
2020-12-31NZ$0.40 B-12.98%
2019-12-31NZ$0.46 B47.43%
2018-12-31NZ$0.31 B43.05%
2017-12-31NZ$0.22 B46.13%
2016-12-31NZ$0.15 B-30.42%
2015-12-31NZ$0.21 B16.34%
2014-12-31NZ$0.18 B-32.15%
2013-12-31NZ$0.27 B905.41%
2012-12-31NZ$27.56 M145.67%
2011-12-31NZ$11.22 M-41.07%
2010-12-31NZ$19.04 M-29.66%
2009-12-31NZ$27.07 M13.92%
2008-12-31NZ$23.76 M27.87%
2007-12-31NZ$18.58 M
2002-12-31NZ$0.38 M-20.66%
2001-12-31NZ$0.48 M72.46%
2000-12-31NZ$0.28 M9.19%
1999-12-31NZ$0.25 M-31.93%
1998-12-31NZ$0.37 M120.23%
1997-12-31NZ$0.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$79.27 B 11,481.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$22.40 B 3,172.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$4.68 B 584.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.55 B 4,217.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
NZ$2.26 B 230.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$88.35 B 12,808.05%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$11.30 B 1,551.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.35 B-47.50%๐Ÿ‡บ๐Ÿ‡ธ USA